儿科肿瘤学成像生物标志物现状白皮书。

IF 2.3 3区医学 Q2 PEDIATRICS

Pediatric Radiology Pub Date : 2025-09-02 DOI:10.1007/s00247-025-06372-6

Rutger A J Nievelstein, Lise Borgwardt, Emilio J Inarejos Clemente, Thekla Von Kalle, Martin Kyncl, Maarten H Lequin, Annemieke S Littooij, Erika Pace, Pier L Di Paolo, Rick R Van Rijn, Julian M M Rogasch, Jurgen Schäfer, Irmina Sefic Pasic, Anita Spezzacatene, Nelleke Tolboom, Simon M Wan, Pietro Zucchetta

{"title":"儿科肿瘤学成像生物标志物现状白皮书。","authors":"Rutger A J Nievelstein, Lise Borgwardt, Emilio J Inarejos Clemente, Thekla Von Kalle, Martin Kyncl, Maarten H Lequin, Annemieke S Littooij, Erika Pace, Pier L Di Paolo, Rick R Van Rijn, Julian M M Rogasch, Jurgen Schäfer, Irmina Sefic Pasic, Anita Spezzacatene, Nelleke Tolboom, Simon M Wan, Pietro Zucchetta","doi":"10.1007/s00247-025-06372-6","DOIUrl":null,"url":null,"abstract":"In paediatric oncology, imaging biomarkers play an increasing role in diagnostic imaging and research. They can be used for prediction, detection, staging, and grading of diseases, as well as for assessment of response to treatment. Imaging biomarkers are complementary to tissue-based biomarkers, enabling a more personalised approach in oncology care. In this white paper by the European Society of Paediatric Radiology (ESPR) Oncology Taskforce and European Association of Nuclear Medicine (EANM) Paediatrics Committee, an overview is given of the current knowledge on the use of imaging biomarkers in general and per tumour group.","PeriodicalId":19755,"journal":{"name":"Pediatric Radiology","volume":" ","pages":""},"PeriodicalIF":2.3000,"publicationDate":"2025-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"White paper on the current state of imaging biomarkers in paediatric oncology.\",\"authors\":\"Rutger A J Nievelstein, Lise Borgwardt, Emilio J Inarejos Clemente, Thekla Von Kalle, Martin Kyncl, Maarten H Lequin, Annemieke S Littooij, Erika Pace, Pier L Di Paolo, Rick R Van Rijn, Julian M M Rogasch, Jurgen Schäfer, Irmina Sefic Pasic, Anita Spezzacatene, Nelleke Tolboom, Simon M Wan, Pietro Zucchetta\",\"doi\":\"10.1007/s00247-025-06372-6\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"In paediatric oncology, imaging biomarkers play an increasing role in diagnostic imaging and research. They can be used for prediction, detection, staging, and grading of diseases, as well as for assessment of response to treatment. Imaging biomarkers are complementary to tissue-based biomarkers, enabling a more personalised approach in oncology care. In this white paper by the European Society of Paediatric Radiology (ESPR) Oncology Taskforce and European Association of Nuclear Medicine (EANM) Paediatrics Committee, an overview is given of the current knowledge on the use of imaging biomarkers in general and per tumour group.\",\"PeriodicalId\":19755,\"journal\":{\"name\":\"Pediatric Radiology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":2.3000,\"publicationDate\":\"2025-09-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pediatric Radiology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s00247-025-06372-6\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"PEDIATRICS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pediatric Radiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00247-025-06372-6","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PEDIATRICS","Score":null,"Total":0}

引用次数: 0

摘要

在儿科肿瘤学中，成像生物标志物在诊断成像和研究中发挥着越来越重要的作用。它们可用于疾病的预测、检测、分期和分级，以及评估对治疗的反应。成像生物标志物是对基于组织的生物标志物的补充，使肿瘤治疗更加个性化。在这份由欧洲儿科放射学会（ESPR）肿瘤学工作组和欧洲核医学协会（EANM）儿科委员会撰写的白皮书中，概述了目前在一般和每个肿瘤组中使用成像生物标志物的知识。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

White paper on the current state of imaging biomarkers in paediatric oncology.

In paediatric oncology, imaging biomarkers play an increasing role in diagnostic imaging and research. They can be used for prediction, detection, staging, and grading of diseases, as well as for assessment of response to treatment. Imaging biomarkers are complementary to tissue-based biomarkers, enabling a more personalised approach in oncology care. In this white paper by the European Society of Paediatric Radiology (ESPR) Oncology Taskforce and European Association of Nuclear Medicine (EANM) Paediatrics Committee, an overview is given of the current knowledge on the use of imaging biomarkers in general and per tumour group.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Pediatric Radiology 医学-核医学

CiteScore

4.40

自引率

17.40%

发文量

300

审稿时长

3-6 weeks

期刊介绍： Official Journal of the European Society of Pediatric Radiology, the Society for Pediatric Radiology and the Asian and Oceanic Society for Pediatric Radiology Pediatric Radiology informs its readers of new findings and progress in all areas of pediatric imaging and in related fields. This is achieved by a blend of original papers, complemented by reviews that set out the present state of knowledge in a particular area of the specialty or summarize specific topics in which discussion has led to clear conclusions. Advances in technology, methodology, apparatus and auxiliary equipment are presented, and modifications of standard techniques are described. Manuscripts submitted for publication must contain a statement to the effect that all human studies have been reviewed by the appropriate ethics committee and have therefore been performed in accordance with the ethical standards laid down in an appropriate version of the 1964 Declaration of Helsinki. It should also be stated clearly in the text that all persons gave their informed consent prior to their inclusion in the study. Details that might disclose the identity of the subjects under study should be omitted.